TREX2
Three prime repair exonuclease 2
Also known as: TREX2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9BQ50
- Gene
- TREX2
- Ensembl
- ENSG00000183479
- Chromosome
- X
- Canonical length
- 236 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted intracellular proteins
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes a nuclear protein with 3' to 5' exonuclease activity. The encoded protein participates in double-stranded DNA break repair, and may interact with DNA polymerase delta. [provided by RefSeq, Nov 2012]
Canonical amino-acid sequenceUniProt
236 residues, UniProt reviewed canonical sequence.
>Q9BQ50|TREX2
1 MSEAPRAETF VFLDLEATGL PSVEPEIAEL SLFAVHRSSL ENPEHDESGA LVLPRVLDKL
61 TLCMCPERPF TAKASEITGL SSEGLARCRK AGFDGAVVRT LQAFLSRQAG PICLVAHNGF
121 DYDFPLLCAE LRRLGARLPR DTVCLDTLPA LRGLDRAHSH GTRARGRQGY SLGSLFHRYF
181 RAEPSAAHSA EGDVHTLLLI FLHRAAELLA WADEQARGWA HIEPMYLPPD DPSLEALocalizationUniProt · AlphaFold · HPA
Whether an antibody against TREX2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.29
- Highest tissue expression
- 26 nTPM
Expression across tissuesHPA
Tissue
- skin: 26 nTPM
- blood vessel: 9 nTPM
- choroid plexus: 5.1 nTPM
- cervix: 5 nTPM
- esophagus: 3.8 nTPM
- vagina: 3.4 nTPM
Single-cell type
- esophageal apical cells: 92 nCPM
- epididymal principal cells: 12 nCPM
- epididymal clear cells: 6.1 nCPM
- paneth cells: 3.9 nCPM
- epididymal basal cells: 3.6 nCPM
- epididymal efferent duct ciliated cells: 3.4 nCPM
Immune cell
- eosinophil: 2.6 nTPM
- basophil: 2.1 nTPM
- intermediate monocyte: 0.3 nTPM
- memory B-cell: 0.3 nTPM
- myeloid DC: 0.3 nTPM
- naive B-cell: 0.3 nTPM
Brain region
- choroid plexus: 12 nTPM
- hippocampal formation: 1.9 nTPM
- cerebral cortex: 1.6 nTPM
- cerebellum: 1.3 nTPM
- medulla oblongata: 1.2 nTPM
- pons: 1.2 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.54
- gnomAD pLI
- 0.45
- gnomAD missense Z
- -0.66
- DepMap mean gene effect
- 0.09
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- 3'-5'-DNA exonuclease activity
- DNA binding
- double-stranded DNA 3'-5' DNA exonuclease activity
- magnesium ion binding
- molecular adaptor activity
- protein homodimerization activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TREX2 as an antibody target. Whether an autoantibody or antibody against TREX2 could matter depends on whether native TREX2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TREX2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TREX2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...